A B S T R A C T Lymphocyte transformation (LT) responses to Chlamydia trachomatis, to four other microbial antigens, and to phytohemagglutinin (PHA) were studied in 201 women during pregnancy and/or 3-18 wk postpartum. The LT responses to all stimulants tested were significantly depressed during pregnancy when compared with postpartum LT responses. This difference occurred whether LT assays were performed in autologous or pooled heterologous plasma collected from nonpregnant donors. Among women studied in the third trimester and again postpartum, the autologous LT stimulation index (LTSI) rose from 1.7 to 3.4 (P < 0.001) with C. trachomatis elementary body antigen, from 3.7 to 7.9 (P < 0.001) with Candida albicans cell wall extract, from 4.5 to 7.8 (P = 0.008) with streptokinase-streptodornase, from 1.7 to 3.0 (P = 0.007) with fluid tetanus toxoid, from 1.7 to 2.8 (P = 0.046) with mumps virus skin test antigen, from 35.5 to 87.0 (P < 0.001) with PHA (2 ,ug/ml), and from 107.2 to 181.9 (P = 0.007) with PHA (10 ,g/ml). LT responses to C. trachomatis were compared in 52 pregnant women and 58 nonpregnant women; all the women had C. trachomatis isolated at the time of LT assay. Using either plasma supplement, the mean LTSI with C. trachomatis antigen was significantly higher in nonpregnant women than in pregnant women, regardless of trimester (P < 0.001). Among 12 women who were 
INTRODUCTION
While humoral immune responses are generally found to be intact during human pregnancy (1, 2) , a large body of evidence suggests that cellular immune responses are impaired. There has been great difficulty in consistently demonstrating depressed immune response in vitro. For instance, it has been reported that the in vitro lymphocyte transformation (LT)' response to phytohemagglutinin (PHA) is depressed (3) (4) (5) (6) (7) (8) , unchanged (9-13), or even increased (14) during pregnancy. Studies in animals have not resolved these discrepancies as some investigators report immunodepression during pregnancy and others do not (15) (16) (17) (18) .
Several reasons may exist to explain these disparate results. Different in vitro assay systems have been used with different culture conditions, different plasma or serum supplements, and different concentrations of stimulants. Small numbers of patients have been stud-ied and often on a single occasion. The LT response data have been expressed in various ways and statistical methods used for analyses have varied from study to study.
We have reexamined the issue of maternal immunoresponsiveness by measuring the in vitro LT response to a variety of microbial antigens and to PHA in large numbers of women during pregnancy and the postpartum period, by prospectively analyzing trends in the LT response throughout pregnancy and the puerperium, and by comparing pregnant women with nonpregnant women. We also identified a group of women with Chlamydia trachomatis infection of the cervix and compared cellular immune responses with chlamydial antigens throughout gestation and the puerperium, and between pregnant and nonpregnant women with a current chlamydial infection. We chose to study infection with C. trachomatis because it is common during pregnancy and because the cellular immune response may be important in host defense against this obligately intracellular pathogen.
We observed that during pregnancy the LT response to PHA and to all microbial antigens was significantly depressed when compared with the postpartum period or when compared with that in nonpregnant women, and that this depression was most marked in the third trimester. LT responsiveness was depressed not only to recall microbial antigens, but also to chlamydial antigens among women with current infection with this agent. Depressed LT responses were observed in both autologous and heterologous (nonpregnant) plasma; this suggests that intrinsic cellular changes in lymphocyte regulation are present during human pregnancy. Depression of the cellular immune response during pregnancy, reflected by depressed LT responsiveness, may help account for the increased susceptibility of the pregnant host to certain infections and to reactivation of previously latent infections.
METHODS

Patient population
201 women were studied during pregnancy or postpartum; 70 of them were seen sequentially-initially in the first or second trimester, subsequently late in the third trimester, and then again at 3-18 wk postpartum. 117 women were studied on at least two occasions and one of the two was during pregnancy. All women were studied at the Prenatal Clinic, University Hospital, Seattle, WA. All women were cultured on at least one occasion for C. trachomatis. This group was selected to include 78 women with a positive cervical culture for C. trachomatis during pregnancy.
58 additional nonpregnant women whose sex partners lacked a history of urethritis and who were detected to have C. trachomatis cervical infection by routine screening cultures were studied at the Sexually Transmitted Disease Clinic, Harborview Medical Center, Seattle, WA.
Microbiologic methods
Cultures of C. trachomatis were obtained with cottontipped or calcium alginate-tipped swabs (type III, Inolex Corp., Park Forest South, IL) from the endocervical canal and were stored in transport media. Specimens were either held at refrigerator temperature if they were to be processed within 24 h or were frozen at -70°C if they were to be tested later. C. trachomatis was isolated by three different methods in two cooperating laboratories over the course of the study: initially, in iododeoxyuridine-treated McCoy cells in inacroculture (19) ; later, in cycloheximide-treated McCoy cells in a microtitre test (20) ; and in some instances, in DEAE dextran-pretreated HeLa 229 cells (21) .
Collection and handling of blood
Blood was collected by venipuncture of a peripheral arm vein into preservative-free, heparinized (0.2 ml/10 ml) sterile tubes. Blood was handled at room temperature and transported to the laboratory usually within 4-6 h of collection. Plasma was separated from cells by centrifugation at 100 g for 10 min. Cells were diluted in Waymouth's medium (Gibco Laboratories, Santa Clara, CA) and processed for separation of the mononuclear cell fraction by density-gradient centrifugation. Plasma samples were frozen at -20°C until tested in the microimmunofluorescence antibody assay.
Serologic test
All plasma samples were tested for C. trachomatis antibody by the microimmunofluorescence technique (22) . Each specimen was screened for antibody with the use of the fluoresceinlabeled goat anti-human immunoglobulins (IgM, IgG, and IgA combined, Hyland Laboratories, Costa Mesa, CA) at three fourfold dilutions against each of the 15 serovars of C. trachomatis elementary bodies. Seropositivity was defined as serum antibody present at a titer >1:8.
Lymphocyte proliferation assay
Mononuclear cells from peripheral blood were isolated by Ficoll-Paque (Pharmacia Fine Chemicals, Piscataway, NJ) centrifugation according to procedures described by Boyum (23) . After washing, the cells were suspended in Waymouth's MB 725/L medium with L-glutamine and counted in a hemocytometer chamber after staining with Turk's solution. Viability, as determined by trypan blue exclusion, was >95%. Cells were adjusted to a density of 1 X 106/ml in medium supplemented with 10% autologous plasma or with 10% heterologous plasma, which had been collected and pooled from six nonpregnant donors, and with 100 U penicillin G/ml and 100 lAg streptomycin/ml. 0.2 ml of this suspension was added to wells of a microtiter plate ( Stimulants used in the LT assay LT assays were performed with C. trachomatis and Candida albicans antigens in all cases. LT assays that were performed with PHA, tetanus toxoid, mumps, and streptokinase-streptodornase (SK-SD) were added later in the study. LT assays were done in autologous plasma in all cases and when cell numbers permitted, in heterologous plasma.
PHA. PHA (PHA-P, Difco Laboratories Inc., Detroit, MI) was obtained as a lyophylized powder and reconstituted in sterile phosphate-buffered saline (PBS). Protein concentration was determined by Lowry's method (24) , and serial dilutions were prepared. Preliminary experiments indicated that 10 ug/ml as final concentration in the well produced the optimal stimulation. PHA was then used at 10 and 2 Mg/ml for the LT assay.
Microbial antigens
C. trachomatis. The method of preparation and purification of chlamydial antigens used in this assay has been described (25 This concentration of purified antigen produces optimal stimulation (25) . Chlamydial antigen was stored at -65°C in aliquots and thawed immediately before use.
C. albicans. This was obtained from Hollister-Stier Laboratories, Spokane, WA (Allergenic Extract) as a sterile extract of dried cell walls which was diluted 1:10 (wt/vol) in 50% glycerine and contained 0.4% phenol. This preparation was extensively dialyzed against PBS under sterile conditions to remove glycerine and phenol. After dialysis, bacterial cultures were done to document lack of bacterial contamination. Preliminary experiments determined that 13.0 ug/ ml final concentration in the well provided optimal stimulation. Samples were aliquoted and frozen at -65°C and thawed immediately before use.
SK-SD. SK (100,000 U)-SD (25,000 U) was obtained from Lederle Laboratories, Pearl River, NY (Varidase) as a lyophilized powder that contained 2.0 mg thimerosol. Expression and analysis of LT data
All statistical tests were performed using 1977-BioMedical Data Program statistical packages. Assay results in autologous and heterologous plasma were analyzed separately for three gestational periods (0-27 wk, 28 wk to delivery, and 3-18 wk postpartum). Further grouping that was based on results of culture and serology for C. trachomatis were occasionally used. The t test was used for comparisons of the LT response in two gestational periods, or in pregnant vs. nonpregnant culture-positive women (26) . Comparisons of the LT response in all three gestational periods, or in relation to various combinations of culture and serology results or the source of plasma were performed using the appropriate linear model (analyses of variance).
Adjustments of experimental (E) counts per minute to reflect changes in control (C) counts per minute are generally used to facilitate qualitative and quantitative analysis of LT response data. However, as evidenced by the number of indices for stimulation used in the literature, the controversy concerning which adjustment for E best reflects the biological nature of its dependence on C has yet to be resolved. Preliminary testing by analysis of covariance of log-transformed, stimulated counts per minute (log E) and control counts per minute (log C) from 31 women tested with both plasma types in all three gestational periods indicated significant dependence of (log E) on (log C) (P < 0.001). This was true in autologous plasma and in heterologous plasma. Fig. 1 , b and c show computer-generated, standard normal plots of two common adjustments of E, the E . C = stimulation index (SI), and E -C, respectively, for all tests done in the third trimester using autologous plasma and C. trachomatis as the stimulant. The log (E/C), i.e. (log E) -(log C) shown in Fig. 1 a, was suggested biologically because of the logarithmic nature of the LT assay and statistically because logarithmic transformations tend to improve heteroscedasticity and normality characteristics. The dashed diagonal line drawn in Fig. 1 a shows the expected distribution of a normally distributed population of numbers. The best approximation to this line is given by the log (E/C). Plots for other gestational periods and stimulants were similar. For these reasons, statistical tests were performed on the log (E/C). To facilitate comparison with previously published data sets, the mean log (E/C) (i.e., lymphocyte transformation stimulation index (LTSI)) has been converted back to the geometric mean SI (10°gIKE/c).
Nevertheless, changes in LTSI can result from changes in either numerator E or denominator C counts per minute. To evaluate whether the observed changes in LTSI reflected changes in E or C, we analyzed data of lymphocyte cultures that were incubated with and without C. trachomatis antigen for 10 C. trachomatis isolate-positive women and 18 C. trachomatis isolate-negative seropositive women; all of these women were studied sequentially during all three gestational periods (Fig. 2) . We chose this subgroup for analysis because it was considered possible that active ongoing infection could cause in vivo stimulation of lymphocytes; this results in elevation of counts per minute of unstimulated in vitro cultures, which thus artificially suppresses the in vitro LTSI. The results from this analysis show that the rise in LTSI postpartum in culture-positive women is not due to a change in unstimulated counts per minute, and that the unstimulated counts per minute in culture-positive women is similar to the unstimulated counts per minute in culture-negative women, as might be expected for a localized infection. 
Depression of Lymphocyte Transformation during Pregnancy 1631
RESULTS
LT response to microbial antigens among women studied during pregnancy and postpartum. Fig. 3 illustrates the mean LTSI that was measured on all 458 assays performed in autologous plasma among the 201 women during the course of pregnancy and 3-18 wk postpartum. Gestation is stratified according to 4 shown for those antigens used to test the largest number of women. A clear trend of decreasing mean LTSI was observed through pregnancy for C. albicans and SK-SD with a nadir in the third trimester. A similar trend was seen for women infected with C. trachomatis during pregnancy; their LT response values fell to levels seen in the uninfected women in the third trimester. The mean LTSI for all of these antigens rose postpartum. Sequential studies among women followed throughout pregnancy and into the postpartum period. 70 women were followed sequentially through pregnancy with at least one LT assay in the first or second trimester, one assay at 32-36 wk gestation, and one assay at 3-18 wk postpartum. Of these women, 31 were tested for LTSI with C. trachomatis antigen in both autologous and pooled heterologous plasma on all occasions, and 26 of the 31 were also tested with C. albicans antigen in both autologous and pooled heterologous plasma on all occasions. In either autologous plasma or pooled heterologous plasma, the LT stimulation indices with both microbial antigens were significantly lower during pregnancy than during the postpartum period (Table I) . Furthermore, two-way analysis of variance showed that although the LTSI with either antigen was significantly lower in heterologous plasma than in autologous plasma (P < 0.0001), the changes that were seen during the course of pregnancy and postpartum were not significantly influenced by plasma source (P = 0.27 and P = 0.39, respectively). 12 of the serially studied women had persistently positive cultures for C. trachomatis at all testing times. As shown in Table III , in both autologous and pooled heterologous plasma, the rise in LT response to C. trachomatis from the third trimester to postpartum was greatest for those with a positive culture for C. trachomatis. This rise was still significant for those who were culture negative but had serum antibody to C. trachomatis; however, there was no significant increase for those who were seronegative. Results were similar when the plasma source was studied more rigorously; a two-way analysis of variance showed that the effect of culture and seropositivity on postpartum LTSI were independent of plasma source (data not shown). Autologous LT response values with chlamydial antigens were lower for all three groups when first or second trimester values were compared with postpartum values; the values reached statistical significance for the culture-positive group (2.49 vs. 4.81, P = 0.03) and the seronegative culture-negative group (0.82 vs. 1.77, P = 0.02). When first or second trimester values were compared with third trimester values, no significant differences were observed among the culture-positive or the culture-negative seropositive groups. Unexpectedly, LT response values were higher LT response to C. trachomatis antigen in women with chlamydial infection: comparison of pregnant or parturient women to nonpregnant women. From the above results, it cannot be determined whether the differences in LT response between pregnant and parturient women are attributable to depressed reactivity during pregnancy or heightened responsiveness postpartum or both. To assess this issue, we compared women at various stages in pregnancy or in the postpartum period with nonpregnant women and examined LT responses to chlamydial and candidal antigens among those with positive C. trachomatis cervical cultures at the time of testing. In both pregnant and nonpregnant women, C. trachomatis infection was initially detected by routine screening examination. Among women that were currently infected with chlamydia, the mean LTSI with chlamydial antigen in both autologous and heterologous plasma was significantly higher among nonpregnant women than among pregnant women, regardless of gestational age (Table IV) . In contrast, the mean LT response to chlamydial antigens in autologous plasma was slightly higher among postpartum women with chlamydial infection than among nonpregnant women with chlamydial infection (P = 0.09), while no difference between postpartum and nonpregnant women was seen with pooled heterologous plasma. The mean LT responses to candidal antigens were significantly lower in the third trimester than postpartum (P < 0.001), and higher postpartum than in nonpregnant women, although this difference was not significant (P = 0.2). Thus, the difference in LTSI between pregnant and parturient women appears to be related to depression during pregnancy.
Although pregnancy plasma has been observed to have potent suppressive activity (27) (28) (29) (30) (31) (32) (33) , we conclude from these analyses that depressed LT responses are apparent during pregnancy both in autologous and heterologous plasma, and that LT depression is not simply due to immunosuppressive activity of pregnancy plasma.
DISCUSSION
This study convincingly establishes in a large number of women studied sequentially that cellular immune function was depressed during pregnancy. We found that LT responses to a variety of microbial antigens and to PHA were depressed. Depression in the LT assay was evident when pregnant subjects were compared with nonpregnant subjects, or when LT responses of individual subjects were compared at different points (36) , smallpox (37) , and poliomyelitis (38) have all been reported to have either higher attack rates or excessive morbidity or mortality for the pregnant host. A recent prospective study of non-A-non-B hepatitis showed that pregnant women had an eightfold excess attack rate when compared with nonpregnant women or with men (34) . Furthermore, infected pregnant women had a 10-fold excess of fulminant hepatic failure when compared with infected nonpregnant women or with men. Mycotic infections also are reported to be more common or more severe in pregnancy. Vaginal isolation rates of C. albicans are increased during pregnancy and abruptly decrease in the puerperium (39) . Coccidiomycosis has been reported to disseminate more frequently in the pregnant host (40) . Untreated malarial infections have been shown to worsen during pregnancy (41) . Among women followed longitudinally before and during pregnancy, parasitemia occurred 4-12 times more frequently during pregnancy than before pregnancy or in the nonpregnant comparison group. Among bacterial infections, leprosy has been noted to downgrade during pregnancy and upgrade in the puerperium. A recent prospective study of 114 women with various forms of leprosy showed that worsening of the type of leprosy occurred in 37% during pregnancy and usually during the third trimester (42) . More 
